The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2016

Filed:

Jun. 23, 2011
Applicants:

Margot Elisabeth Francoise Schoonneveld-bergmans, Delft, NL;

Wilbert Herman Marie Heijne, Dordrecht, NL;

Rene Marcel DE Jong, Amsterdam, NL;

Robbertus Antonius Damveld, Berkel en Rodenrijs, NL;

Inventors:
Assignee:

DSM IP ASSETS B.V., Heerlen, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/42 (2006.01); C12N 15/63 (2006.01); A01H 5/00 (2006.01); C12P 7/14 (2006.01); C12N 15/82 (2006.01); C12P 19/02 (2006.01); C12P 19/14 (2006.01);
U.S. Cl.
CPC ...
C12N 9/42 (2013.01); C12N 9/2434 (2013.01); C12N 9/2437 (2013.01); C12N 9/2445 (2013.01); C12N 15/8257 (2013.01); C12P 19/02 (2013.01); C12P 19/14 (2013.01); C12Y 302/01021 (2013.01); C12P 2203/00 (2013.01); Y02P 20/52 (2015.11);
Abstract

The invention relates to a polypeptide comprising the amino acid sequence set out in SEQ ID NO: 2 or an amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 1, or a variant polypeptide or variant polynucleotide thereof, wherein the variant polypeptide has at least 96% sequence identity with the sequence set out in SEQ ID NO: 2 or the variant polynucleotide encodes a polypeptide that has at least 96% sequence identity with the sequence set out in SEQ ID NO: 2. The invention features the full length coding sequence of the novel gene as well as the amino acid sequence of the full-length functional polypeptide and functional equivalents of the gene or the amino acid sequence. The invention also relates to methods for using the polypeptide in industrial processes. Also included in the invention are cells transformed with a polynucleotide according to the invention suitable for producing these proteins.


Find Patent Forward Citations

Loading…